|
[1]
|
Development of an UPLC-QTOF-MS Method for the Simultaneous Estimation of Dronedarone and its Unlisted Pharmacopoeial Impurities
Journal of Analytical Chemistry,
2023
DOI:10.1134/S1061934823070122
|
|
|
|
|
[2]
|
Development and validation of two spectrophotometric methods for the estimation of Dronedarone impurity molecule: (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
Materials Today: Proceedings,
2021
DOI:10.1016/j.matpr.2020.11.913
|
|
|
|
|
[3]
|
The silent development of counterfeit medications in developing countries – A systematic review of detection technologies
International Journal of Pharmaceutics,
2020
DOI:10.1016/j.ijpharm.2020.119702
|
|
|
|
|
[4]
|
The silent development of counterfeit medications in developing countries – A systematic review of detection technologies
International Journal of Pharmaceutics,
2020
DOI:10.1016/j.ijpharm.2020.119702
|
|
|
|
|
[5]
|
Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC–MS/TOF and MS n studies
Journal of Pharmaceutical and Biomedical Analysis,
2016
DOI:10.1016/j.jpba.2015.10.028
|
|
|
|
|
[6]
|
A review on dronedarone: Pharmacological, pharmacodynamic and pharmacokinetic profile
Journal of Acute Disease,
2016
DOI:10.1016/j.joad.2015.10.002
|
|
|
|
|
[7]
|
Synthesis and characterization of new related substances of the antiarrhythmic drug dronedarone hydrochloride
Journal of Pharmaceutical and Biomedical Analysis,
2015
DOI:10.1016/j.jpba.2015.06.026
|
|
|
|
|
[8]
|
Fast Stability Indicating UPLC Method for Quantitative Analysis of Dronedarone in Pharmaceutical Dosage Form: Force Degradation Study
ISRN Chromatography,
2014
DOI:10.1155/2014/962130
|
|
|
|
|
[9]
|
Stability Indicating RP-HPLC Method for the Determination of Dronedarone Hydrochloride and Its Potential Process-Related Impurities in Bulk Drug and Pharmaceutical Dosage Form
American Journal of Analytical Chemistry,
2013
DOI:10.4236/ajac.2013.46041
|
|
|
|
|
[10]
|
Determination of dronedarone in the pharmaceutical dosage form by a stability-indicating micellar electrokinetic chromatography method
Analytical Methods,
2013
DOI:10.1039/c3ay40311d
|
|
|
|